REGENXBIO (RGNX) director buys stock, gets new equity awards
Rhea-AI Filing Summary
REGENXBIO Inc. (RGNX) director Gregory Austin Ciongoli reported multiple equity transactions. He purchased 49,196 shares of common stock on August 26, 2026 at a weighted average price of $9.1411 per share in open-market trades, and 53,407 shares on August 27, 2026 at a weighted average price of $9.3560 per share in open-market trades.
On August 25, 2026, he also received an equity compensation package consisting of 15,432 shares of time-based restricted stock units that vest in three equal annual installments on August 25, 2027, 2028 and 2029, and a stock option for 69,609 shares of common stock at an exercise price of $8.91 per share, vesting one-third on August 25, 2027 and the remainder in equal monthly installments over the following 24 months.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Buyer: 118,035 shares
Net Buy
4 txns
Insider
Ciongoli Gregory Austin
Role
Director
Bought
102,603 shs ($949K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F3 | 53,407 | $9.356 | $500K |
| Purchase | Common Stock F2 | 49,196 | $9.1411 | $450K |
| Grant/Award | Stock Options (Right to buy) F4 | 69,609 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 15,432 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (Right to buy) — 69,609 shares (Direct);
Common Stock — 118,035 shares (Direct)
Footnotes (4)
- F1. Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 1/3rd of the shares subject to the RSU award shall vest on each of August 25, 2027, August 25, 2028 and August 25, 2029, while the recipient provides continuous service to the Issuer.
- F2. Represents shares purchased in an open-market transaction. The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $8.67 to $9.35. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. Represents shares purchased in an open-market transaction. The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $9.17 to $9.4525. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4. The option will vest over a three year period, with 1/3rd of the option vesting on August 25, 2027 and the remaining portion of the option vesting in equal monthly installments over the 24 months thereafter, while the optionee provides continuous service to the Issuer.
Key Figures
Common stock purchased August 26, 2026: 49,196 shares at $9.1411 per share
Common stock purchased August 27, 2026: 53,407 shares at $9.3560 per share
RSU grant: 15,432 shares of common stock
+5 more
8 metrics
Common stock purchased August 26, 2026
49,196 shares at $9.1411 per share
Open-market purchase by director Gregory Austin Ciongoli
Common stock purchased August 27, 2026
53,407 shares at $9.3560 per share
Open-market purchase by director Gregory Austin Ciongoli
RSU grant
15,432 shares of common stock
Time-based RSU award granted August 25, 2026
RSU vesting schedule
1/3 on each of August 25, 2027, 2028, 2029
Vesting contingent on continuous service
Stock option grant
69,609 shares at $8.91 exercise price
Option granted August 25, 2026, right to buy common stock
Option vesting start date
August 25, 2027
1/3 vests on this date; remainder monthly over 24 months
Option expiration date
August 25, 2036
Expiration of stock option for 69,609 shares
Net common shares bought in open market
102,603 shares
Sum of August 26 and 27, 2026 open-market purchases
Key Terms
restricted stock unit, open-market transaction, weighted average price, vesting, +1 more
5 terms
restricted stock unit financial
"Represents shares of common stock underlying a time-based restricted stock unit award"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
open-market transaction financial
"Represents shares purchased in an open-market transaction"
An open-market transaction is a buy or sell of a company's shares or other securities conducted on a public exchange at the current market price, rather than through a private agreement. Investors watch these trades because they change the number of shares available and can move the price immediately—similar to how a large purchase at a busy store can raise demand and affect the checkout price—so such activity can signal market sentiment and alter ownership stakes.
weighted average price financial
"The price reported in Column 4 is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
vesting financial
"1/3rd of the shares subject to the RSU award shall vest on each"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"The option will vest over a three year period, with 1/3rd of the option vesting"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What insider buying did RGNX director Gregory Austin Ciongoli report?
Gregory Austin Ciongoli reported buying 49,196 shares of REGENXBIO common stock on August 26, 2026 at a weighted average price of $9.1411, and 53,407 shares on August 27, 2026 at a weighted average price of $9.3560 in open-market transactions.
What equity awards did RGNX grant to Gregory Austin Ciongoli on August 25, 2026?
On August 25, 2026, Gregory Austin Ciongoli received 15,432 RSU shares of common stock and a stock option covering 69,609 shares of common stock with an exercise price of $8.91 per share, both reported as directly owned.
How do the RSUs granted to Gregory Austin Ciongoli at RGNX vest?
The 15,432 RSU shares vest over three years: one-third of the shares vest on each of August 25, 2027, August 25, 2028, and August 25, 2029, while he provides continuous service to REGENXBIO.
What are the vesting terms of Gregory Austin Ciongoli’s RGNX stock options?
The option for 69,609 shares at an exercise price of $8.91 per share vests over three years: one-third vests on August 25, 2027, and the remaining two-thirds vest in equal monthly installments over the following 24 months, subject to continuous service.
Were the recent RGNX insider stock purchases made in the open market?
Yes. Footnotes state the purchases of 49,196 shares on August 26, 2026 and 53,407 shares on August 27, 2026 were open-market transactions, each executed in multiple trades within specified price ranges and reported at a weighted average price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
